HemoGenyx Pharmaceuticals Plc (GB:HEMO)
LSE:HEMO
Holding GB:HEMO?
Track your performance easily

HemoGenyx Pharmaceuticals Plc (HEMO) Financial Statements

14 Followers

HemoGenyx Pharmaceuticals Plc Financial Overview

HemoGenyx Pharmaceuticals Plc's market cap is currently ―. The company's EPS TTM is p-0.004; its P/E ratio is -3.23; HemoGenyx Pharmaceuticals Plc is scheduled to report earnings on April 25, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 5.80M£ 6.84M£ 10.56M£ 1.81M£ 3.36M
Total Assets£ 7.84M£ 8.52M£ 11.11M£ 2.66M£ 3.88M
Total Debt£ 0.00£ 10.15K£ 1.53M£ 1.63M£ 1.75M
Net Debt£ -5.80M£ -6.83M£ -9.03M£ -184.17K£ -1.61M
Total Liabilities£ 963.16K£ 352.84K£ 1.80M£ 1.79M£ 1.92M
Stockholders Equity£ 6.92M£ 8.19M£ 9.32M£ 890.84K£ 1.96M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

HemoGenyx Pharmaceuticals Plc Earnings and Revenue History

HemoGenyx Pharmaceuticals Plc Debt to Assets

HemoGenyx Pharmaceuticals Plc Cash Flow

HemoGenyx Pharmaceuticals Plc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis